Filing Details

Accession Number:
0001209191-15-049816
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-03 18:35:27
Reporting Period:
2015-06-01
Filing Date:
2015-06-03
Accepted Time:
2015-06-03 18:35:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1373707 Tetraphase Pharmaceuticals Inc TTPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296998 Guy Macdonald 480 Arsenal St. Suite 110
Watertown MA 02472
President And Chief Executive Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-01 10,000 $7.94 81,087 No 4 M Direct
Common Stock Disposition 2015-06-01 10,000 $41.86 71,087 No 4 S Direct
Common Stock Disposition 2015-06-01 1,087 $41.98 70,000 No 4 S Direct
Common Stock Acquisiton 2015-06-01 20,000 $0.87 90,000 No 4 M Direct
Common Stock Disposition 2015-06-01 5,000 $41.92 85,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2015-06-01 10,000 $0.00 10,000 $7.94
Common Stock Employee Stock Option (right to buy) Disposition 2015-06-01 5,000 $0.00 5,000 $0.87
Common Stock Employee Stock Option (right to buy) Acquisiton 2015-06-01 15,000 $0.00 15,000 $0.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
210,000 2023-05-14 No 4 M Direct
84,323 2019-09-10 No 4 M Direct
69,323 2019-09-10 No 4 M Direct
Footnotes
  1. The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2014.
  2. The amount of securities beneficially owned by the reporting person following the transaction reported on this Form 4 reflects the purchase by the reporting person of 550 shares of common stock on May 14, 2015 pursuant to the issuer's 2014 Employee Stock Purchase Plan.
  3. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $41.20 to $43.52 per share. The reporting person herby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission,the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  4. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $41.88 to $41.93 per share. The reporting person herby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission,the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  5. Vests as to 25% of the original number of shares granted on 5/15/2013 and further vests as to an additional 6.25% of the original number of shares granted at the end of each successive three-month period thereafter until 5/15/2017.
  6. Fully vested.